{"id":"https://openalex.org/W7225099446","doi":"https://doi.org/10.5281/zenodo.23877141","title":"Disproportionality of Brugada Syndrome with Expert-Defined High-Risk Medications in the FDA Adverse Event Reporting System (FAERS), 2021\u20132025","display_name":"Disproportionality of Brugada Syndrome with Expert-Defined High-Risk Medications in the FDA Adverse Event Reporting System (FAERS), 2021\u20132025","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225099446","doi":"https://doi.org/10.5281/zenodo.23877141"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23877141","doi":"https://doi.org/10.5281/zenodo.23877141","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23877141","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23877141","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148555657","display_name":"Yuvraj Jadhav","orcid":"https://orcid.org/0009-0008-4682-1601","observed_orcids":["https://orcid.org/0009-0008-4682-1601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuvraj Jadhav","raw_affiliation_strings":["Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159837042","display_name":"Sakshi Jadhav","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sakshi Jadhav","raw_affiliation_strings":["Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116607900","display_name":"Sanika Gurav","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanika Gurav","raw_affiliation_strings":["Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160339350","display_name":"Sanket Harimakar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanket Harimakar","raw_affiliation_strings":["Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Progressive Education Society's Modern College of Pharmacy, Nigdi, Pune-411044, Maharashtra, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83958947,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.07609999924898148,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brugada-syndrome","display_name":"Brugada syndrome","score":1.0},{"id":"https://openalex.org/keywords/high-risk-medications","display_name":"high-risk medications","score":0.6449999809265137},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.6859999895095825},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.9409999847412109},{"id":"https://openalex.org/keywords/cardiac-channelopathies","display_name":"cardiac channelopathies","score":0.6620000004768372},{"id":"https://openalex.org/keywords/ventricular-arrhythmias","display_name":"ventricular arrhythmias","score":0.7649999856948853},{"id":"https://openalex.org/keywords/spontaneous-adverse-event-reporting","display_name":"spontaneous adverse event reporting","score":0.6470000147819519},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.41499999165534973},{"id":"https://openalex.org/keywords/age-and-sex-stratification","display_name":"age and sex stratification","score":0.6700000166893005},{"id":"https://openalex.org/keywords/reporting-odds-ratio","display_name":"reporting odds ratio","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C2777382798","wikidata":"https://www.wikidata.org/wiki/Q599683","display_name":"Brugada syndrome","level":2,"score":0.9416999816894531},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8924000263214111},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.6168000102043152},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.512499988079071},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46129998564720154},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.4147000014781952},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.41359999775886536},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4072999954223633},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4034000039100647},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.38940000534057617},{"id":"https://openalex.org/C2781005686","wikidata":"https://www.wikidata.org/wiki/Q848662","display_name":"Ventricular fibrillation","level":2,"score":0.36169999837875366},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.3537999987602234},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.3433000147342682},{"id":"https://openalex.org/C2775935837","wikidata":"https://www.wikidata.org/wiki/Q202837","display_name":"Sudden cardiac death","level":2,"score":0.34139999747276306},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34119999408721924},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3361000120639801},{"id":"https://openalex.org/C3020404979","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk stratification","level":2,"score":0.3346000015735626},{"id":"https://openalex.org/C2776767690","wikidata":"https://www.wikidata.org/wiki/Q587420","display_name":"Myotonia congenita","level":4,"score":0.289900004863739},{"id":"https://openalex.org/C2777989426","wikidata":"https://www.wikidata.org/wiki/Q2936142","display_name":"Channelopathy","level":2,"score":0.28049999475479126},{"id":"https://openalex.org/C3020169349","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug event","level":3,"score":0.2777999937534332},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.2766000032424927},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.273499995470047},{"id":"https://openalex.org/C2777233412","wikidata":"https://www.wikidata.org/wiki/Q13365162","display_name":"Bundle branch block","level":3,"score":0.27090001106262207},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2587999999523163}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23877141","doi":"https://doi.org/10.5281/zenodo.23877141","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23877141","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23877142","doi":"https://doi.org/10.5281/zenodo.23877142","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23877142","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23877141","doi":"https://doi.org/10.5281/zenodo.23877141","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23877141","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142559830","https://openalex.org/W1990826945","https://openalex.org/W4280619143","https://openalex.org/W2344464904","https://openalex.org/W4328047915","https://openalex.org/W2034188283","https://openalex.org/W2793238221","https://openalex.org/W3120904462","https://openalex.org/W7124530490","https://openalex.org/W4301036851"],"abstract_inverted_index":{"Brugada":[0,91,151,196,204,249],"syndrome":[1,92,152],"is":[2,337],"a":[3,61,327],"cardiac":[4],"channelopathy":[5],"in":[6,49,202,215],"which":[7],"certain":[8],"medications":[9,27,109,309],"can":[10],"unmask":[11],"the":[12,69,96,116,272,280,341],"characteristic":[13],"electrocardiographic":[14],"phenotype":[15],"and":[16,34,90,143,161,165,174,232,246,287,359],"precipitate":[17],"malignant":[18],"ventricular":[19],"arrhythmias.":[20],"BrugadaDrugs.org":[21,342],"provides":[22],"expert":[23],"classifications":[24],"separating":[25],"implicated":[26],"into":[28],"RED":[29,104,198,231,251,304,331],"(contraindicated":[30],"or":[31,105,113,369],"best":[32],"avoided)":[33,37],"ORANGE":[35,106,211,260,296,333],"(preferably":[36],"categories.":[38],"Whether":[39],"these":[40],"expert-defined":[41,318],"categories":[42,117,319],"correspond":[43],"to":[44,103,140],"real-world":[45],"spontaneous":[46],"reporting":[47],"patterns":[48],"large":[50],"postmarketing":[51],"databases":[52],"has":[53],"not":[54,119,303,313,347,361],"been":[55],"systematically":[56],"evaluated.":[57],"This":[58],"study":[59],"performed":[60],"retrospective":[62],"case/non-case":[63],"disproportionality":[64],"analysis":[65,181],"of":[66,176,195,351,366],"reports":[67,194,243],"from":[68,78],"US":[70],"FDA":[71],"Adverse":[72],"Event":[73],"Reporting":[74,122],"System":[75],"(FAERS)":[76],"submitted":[77],"Q1":[79],"2021":[80],"through":[81],"Q4":[82],"2025.":[83],"Reports":[84],"were":[85,118,131,154,225,282,320],"deduplicated":[86,186],"by":[87,163],"case":[88],"identifier,":[89],"was":[93,200,213,253,293],"identified":[94],"using":[95,179],"MedDRA":[97],"Preferred":[98],"Term":[99],"\"Brugada":[100],"syndrome\".":[101],"Exposure":[102],"drugs":[107,145,178],"included":[108],"recorded":[110,201,214],"as":[111,364],"primary":[112],"secondary":[114],"suspects;":[115],"mutually":[120,240],"exclusive.":[121],"odds":[123,258],"ratios":[124],"(RORs)":[125],"with":[126,133,146,255,322,326,340],"95%":[127,208,220,264],"confidence":[128],"intervals":[129],"(CIs)":[130],"calculated,":[132],"Benjamini\u2013Hochberg":[134],"false":[135],"discovery":[136],"rate":[137],"correction":[138],"applied":[139],"individual-drug":[141],"analyses,":[142],"only":[144],"at":[147],"least":[148],"three":[149],"exposed":[150,242],"cases":[153,205,217],"retained.":[155],"Sensitivity":[156],"analyses":[157],"examined":[158],"primary-suspect":[159],"exposure":[160,199,212,252,261],"stratification":[162],"sex":[164],"age.":[166],"Multivariable":[167],"logistic":[168],"regression":[169],"adjusted":[170,257],"for":[171,230,237,295,330],"age,":[172],"sex,":[173],"number":[175],"suspect":[177],"complete-case":[180],"(n":[182],"=":[183,298,306],"4,399,497).":[184],"The":[185,335],"dataset":[187],"contained":[188],"7,660,722":[189],"FAERS":[190],"cases,":[191],"including":[192],"406":[193],"syndrome.":[197],"106":[203],"(ROR":[206,218,275],"73.54,":[207],"CI":[209,221,228,235,265],"58.91\u201391.79);":[210],"153":[216],"28.24,":[219],"23.10\u201334.52).":[222],"Adjusted":[223],"ORs":[224],"104.12":[226],"(95%":[227,234],"79.23\u2013136.83)":[229],"23.11":[233],"18.23\u201329.30)":[236],"ORANGE.":[238],"In":[239],"exclusive":[241],"(72":[244],"RED-only":[245],"119":[247],"ORANGE-only":[248],"cases),":[250],"associated":[254,321],"higher":[256],"than":[259,332],"(OR":[262],"5.54,":[263],"4.06\u20137.54).":[266],"Among":[267],"individual":[268],"drugs,":[269],"flecainide":[270],"had":[271],"largest":[273,281],"signal":[274,329],"320.03);":[276],"among":[277],"non-cardiac":[278],"agents":[279],"fluvoxamine":[283],"(190.48),":[284],"nortriptyline":[285],"(166.37),":[286],"bupropion":[288],"(70.89).":[289],"A":[290],"sex-by-exposure":[291],"interaction":[292],"observed":[294],"(p":[297,305],"1.66":[299],"\u00d7":[300],"10\u207b\u2075)":[301],"but":[302,312,345],"0.842).":[307],"Comparator":[308],"produced":[310],"smaller":[311],"uniformly":[314],"null":[315],"estimates.":[316],"Both":[317],"marked":[323],"disproportionate":[324],"reporting,":[325],"stronger":[328],"drugs.":[334],"pattern":[336],"directionally":[338],"consistent":[339],"risk":[343],"hierarchy":[344],"does":[346],"constitute":[348],"independent":[349],"validation":[350],"clinical":[352,371],"risk.":[353,372],"These":[354],"findings":[355],"represent":[356],"pharmacovigilance":[357],"signals":[358],"should":[360],"be":[362],"interpreted":[363],"evidence":[365],"causality,":[367],"incidence,":[368],"absolute":[370]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-03T00:00:00"}